)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Biome Australia
Biome Australia (BIO) investor relations material
Biome Australia Q1 2027 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 TU earnings summary25 Oct, 2026
Executive summary
Q1 FY27 brought record pharmacy sell-through, onshore production commencement, a China distribution agreement and continued BMB18 trial recruitment.
A second consecutive full-year net profit was reported for FY26; Q1 FY27 generated $100k net operating cash inflow.
Financial highlights
Customer cash receipts were $6.5m, up 10% QoQ from $5.9m, reflecting sales growth in Australia and international markets.
Cash was $3.4m at 30 September 2026, down $170k from Q4 FY26; total available funding was $6.5m.
Product manufacturing and operating cost payments were $2.9m, down 17% YoY; direct brand marketing cash spend was $480k.
Outlook and guidance
Australian-made Activated Probiotics are expected on pharmacy shelves from November 2026; onshore manufacturing is expected to structurally lower COGS and working capital needs over time.
China cross-border e-commerce launch remains planned within FY27, subject to a master distribution agreement; volumes, purchase targets and launch date will be confirmed on execution.
Biome Daily 60 and Biome Daily Kids 60 packs are scheduled to launch in Q2 FY27.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Biome Australia
- FY26 saw 30% revenue growth, record profit, and strategic moves for future margin expansion.BIO
H2 2026 - FY26 delivered record revenue, profit, and margin, with global expansion and new China entry ahead.BIOInvestor presentation
- Record FY26 revenue, strong cash flow, and top probiotic market position achieved.BIOQ4 2026 TU
- Premium, practitioner-only probiotics scaled globally, achieving strong growth and margins.BIOInvestor presentation
- Record revenue and profit growth, margin expansion, and clinical strength drive global momentum.BIOStatus update
- Achieved first net profit and 41.6% revenue growth, with strong global expansion and innovation.BIOH2 2025
- Sales revenue up 80% to $13.01m, gross margin over 60%, and positive EBITDA in H2 FY24.BIOH2 2024
- Record revenue and profit growth, strong margins, and expanding international presence.BIOH1 2026
- First net profit, record sales, and expanded distribution highlight strong H1 FY25.BIOH1 2025
Next Biome Australia earnings date
AGM 202625 Nov, 2026
Biome Australia
Next Biome Australia earnings date
AGM 202625 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Biome Australia Limited is an Australian health and wellness company that develops, manufactures, and distributes probiotic, nutraceutical, and complementary medicine products. The company's offerings are aimed at supporting gut health, immune function, and overall well-being, leveraging scientific research in microbiome health to create innovative formulations. Biome Australia serves healthcare practitioners, pharmacies, and consumers, providing products designed to meet various health needs. Biome Australia Limited is headquartered in Melbourne, Australia, and its shares are listed on the ASX.